RST-SST Touch™ Rheometer

Brookfield's high end, touch screen rheometer uses vane spindle geometry in both controlled stress and controlled rate modes to characterize creep behavior as well as yield stress and viscosity profiles.

By | March 3, 2014

Request More Information

Brookfield's high end, touch screen rheometer uses vane spindle geometry in both controlled stress and controlled rate modes to characterize creep behavior as well as yield stress and viscosity profiles.

Vane spindle geometry allows spindle insertion into the material without compromising sample structure. This unit has quick connect coupling for rapid attachment of the spindles. Also, a rapid spindle insertion without compromising sample structure and a quick and easy test method.

The RST-SST quantifies meaningful properties such as stiffness, wobbliness, sloppiness, consistency and texture. Data is recorded and analyzed using optional Rheo 3000 Software that allows for PC control and data acquisition and analysis of multiple test files.

Features and Benefits include:

  • Spindle Barcode for auto spindle recognition
  • Measured values in yield stress, shear modulus, recovery, and creep
  • Capable of measurements in BU units for viscous materials such as joint compound
  • Quick and easy automatic or manual gap setting
  • User-friendly LCD touch screen with graphical display
  • 11 memory slots for structured multi-step test programs
  • Auto spindle identity recognition
  • 21 CFR compliance for controlled user access and data security
Request More Information

Product Details

AMETEK Brookfield RST-SST Touch Rheometer

image of: AMETEK Brookfield RST-SST Touch Rheometer

Request More Information

Your Request
About You
Enter text from the image above:

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham